CA2721007C — Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
Assigned to Neurodyn Life Sciences Inc · Expires 2014-04-29 · 12y expired
What this patent protects
The present invention refers to selected galantamine derivatives having high efficacy in treatment of human brain diseases and low side effects, and having the general formula: (see above formula) with R1 being a substituent having particular sterical and hydrophobic properties.
USPTO Abstract
The present invention refers to selected galantamine derivatives having high efficacy in treatment of human brain diseases and low side effects, and having the general formula: (see above formula) with R1 being a substituent having particular sterical and hydrophobic properties.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.